Study to Evaluate the Effects of Oral Contraceptive on Hemostatic Parameters in Healthy Women
- Study Title
- A Multicenter Study to Evaluate the Effects of a 91-Day Extended Cycle Oral Contraceptive on Hemostatic Parameters in Healthy Women
- Teva Identifier
- PSE-HSP-203 | 2010-023215-34
- ClinicalTrials.gov Identifier
- NCT01252186
- Study Status
- Completed
- Trial Condition(s)
- Hemostasis | Oral Contraceptive
- Interventions
- Drug: 91-day Levonorgestrel Oral Contraceptive | Drug: 28-day Levonorgestrel Oral Contraceptive | Drug: 28-day Desogestrel Oral Contraceptive
Study Description
Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female
- Age group
- Adult
- Age Range
- 18 Years to 40 Years
- Trial Duration
- 11/01/2010 - 12/01/2011
- Phase
- Phase 2
